Generex Biotechnology News

News on Generex Biotechnology (Ticker: GNBT) continually updated from thousands of sources around the net.

Wednesday Feb 1 | BioSpace

Generex Biotechnology Corporation Announces Patent Award for its Core Vaccine Technologies in Japan

A number of products developed with this technology are currently in clinical development.

Comment?

Tue Jan 31, 2012

Freshnews

Generex Announces $2.00 Million Capital Investment

Generex Biotechnology Corporation today announced that it entered into a securities purchase agreement with certain institutional investors on January 31, 2012.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Jan 25, 2012

BioSpace

Generex Biotechnology Corporation Secures Commitments for $3.6M Capital Raise

Interest on the loans is payable monthly at the rate of 10% per annum . "This capital infusion will permit the Company to advance its redevelopment plans, and to do so in a manner that is not dilutive to our stockholders," commented , 2012.

Comment?

Mass High Tech

Insulin spray maker Generex pulls in $3.55M in loans

Generex Biotechnology Corp., of both Worcester and Toronto, is getting a boost of about $3.55 million U.S. dollars through two loans expected to support its redevelopment plans, the company said in a news release today.

Comment?

Tue Jan 17, 2012

Rehab Management

Generex Subsidiary Antigen Express Featured on SNN Stock News Now;...

The company further outlined advantages of the Ii-Key immunotherapeutic vaccine.

Comment?